The Cooper (STU:CP60) Common Stock : €20 Mil (As of Apr. 2024)

View and export this data going back to 1983. Start your Free Trial

What is The Cooper Common Stock?

The Cooper's quarterly common stock increased from Oct. 2023 (€5 Mil) to Jan. 2024 (€20 Mil) and increased from Jan. 2024 (€20 Mil) to Apr. 2024 (€20 Mil).

The Cooper's annual common stock increased from Oct. 2021 (€5 Mil) to Oct. 2022 (€5 Mil) but then declined from Oct. 2022 (€5 Mil) to Oct. 2023 (€5 Mil).

The Cooper Common Stock Historical Data

The historical data trend for The Cooper's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Common Stock Chart

The Cooper Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Common Stock

Get a 7-Day Free Trial

4.79

4.51

4.66

5.48

5.11

The Cooper Quarterly Data
	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
Common Stock	Get a 7-Day Free Trial															4.93	4.88	5.11	19.83	20.22

The Cooper Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

The Cooper (STU:CP60) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (STU:CP60) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

COO:USA COO:Mexico C1OO34:Brazil

Address

6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583

Website

https://www.coopercos.com

The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

The Cooper (STU:CP60) Headlines

No Headlines